Lantheus Holdings, Inc.
LNTH- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001521036
No open-market purchases or sales by Lantheus Holdings, Inc. insiders were filed in the last 90 days; 467 institutions reported holding it in 13F filings for Q2 2026, worth $8.34B in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Lantheus Holdings, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Of which not filed for Q1 2024 | Q1 2024 | Change |
|---|---|---|---|---|
| Holders | 401 | 4 | 409 | +12 |
| Shares | 69.5M | 400.2K | 67.3M | −1.76M (−2.5%) |
| Value | $4.31B | $24.8M | $4.19B | −$92.2M (−2.2%) |
4 institutions that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (73)
Institutions that held Lantheus Holdings, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
Sold out (61)
Institutions that held Lantheus Holdings, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
Not filed for Q1 2024 yet (4)
Institutions that held Lantheus Holdings, Inc. at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Putnam Investments LLC | 354,011 | $21.9M |
| Pavadi Capital LLC | 40,492 | $2.51M |
| AtonRa Partners | 5,496 | $340.8K |
| Coppell Advisory Solutions LLC | 152 | $9.42K |